Emergency use authorization for intradermal administration of Jynneos; treatment approved for endometriosis pain; Amazon among the companies to receive a FDA Warning Letter for selling unapproved drugs; a diabetes drug is found to contain a possible carcinogen; and a new scale that measures peripheral impedance and pulse rate.
Findings seen among individuals who received at least three mRNA vaccine doses, subsequently diagnosed with COVID-19 during omicron surge
Blacks, Hispanics less likely than Whites to undergo coronary angiography, PCI for acute non-ST-segment elevation myocardial infarction
PF-07265803 is an investigational selective, oral, small-molecule inhibitor of the p38a mitogen activated protein kinase pathway.
The APOLLO-B study included patients 18 years of age and older with ATTR amyloidosis (hereditary or wild-type) with cardiomyopathy.
Findings may aid physicians in their clinical decision-making in the absence of randomized clinical trial data, according to investigators.
Incidence of myocarditis probably higher after vaccination with mRNA-1273 vs BNT162b2, lower with increased interval between doses
Findings show lower hospitalization risk 31 to 120 days after COVID-19 infection
Sotagliflozin is an investigational dual sodium-glucose co-transporter types 1 and 2 (SGLT1, SGLT2) inhibitor.
For women, inverse slope between potassium intake and SBP steeper for those within highest versus lowest tertile of sodium intake
